Towards a diagnosis of heparin-induced thrombocytopenia after cardiopulmonary bypass

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 11, 2004, Pages 1879-1881

  Matthai Jr , W H ^a   Cines, D B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGATROBAN; DANAPAROID; HEPARIN; LEPIRUDIN;

ANTIBODY PRODUCTION; ANTICOAGULATION; ARTICLE; BLEEDING; CARDIOPULMONARY BYPASS; CLINICAL OBSERVATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DRUG MONITORING; HEPARIN INDUCED THROMBOCYTOPENIA; HIGH RISK PATIENT; HUMAN; HYPOTENSION; INFECTION; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOSIS; THROMBOEMBOLISM;

ALGORITHMS; CARDIOPULMONARY BYPASS; DIAGNOSIS, DIFFERENTIAL; HEPARIN; HUMANS; PLATELET COUNT; THROMBOCYTOPENIA;

EID: 13244298145     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.01016.x     Document Type: Article

References (20)

1. Warkentin T, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thoracic Surg 2004; 76: 638-48.
2. Liu JC, Lewis BE, Steen LH, Grassman ED, Bakhos M, Blakeman B, Wrona L, Leya F. Patency of coronary artery bypass grafts in patients with heparin-induced thrombocytopenia. Am J Cardiol 2002; 89: 979-81.
3. Walls JT, Curtis JJ, Silver D, Boley TM, Schmaltz RA, Nawarawong W. Heparin-induced thrombocytopenia in open heart surgical patients: sequelae of late recognition. Ann Thorac Surg 1992; 53 787-91.
4. Lewis BE, Wallis DE, Berkowitz SD, Matthai WH, Fareed J, Walenga JM, Bartholomew J, Sham R, Lerner RG, Zeigler ZR, Rustagi PK, Jang IK, Rifkin SD, Moran J, Hursting MJ, Kelton JG; ARG-911 Study Investigators. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 2001; 103: 1838-43.
5. Greinacher A, Volpel H, Janssens U, Hach-Wunderle V, Kemkes-Matthes B, Eichler P, Mueller-Velten HG, Potzsch B. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. Circulation 1999; 99: 73-80.
6. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003; 121: 535-5.
7. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001; 344: 1286-92.
8. Rice L, Attisha WK, Drexler A, Francis JL. Delayed-onset heparin-induced thrombocytopenia. Ann Int Med 2002; 136: 210-5.
9. Warkentin TE, Kelton JE. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Int Med 2001; 135: 502-6.
10. Bauer TL, Arepally G, Konkle BA, Mestichelli B, Shapiro SS, Cines DB, Poncz M, McNulty S, Amiral J, Hauck WW, Edie RN, Mannion JD. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass. Circulation 1997; 95 1242-6.
11. Risch L, Bertschmann W, Heijnen IAFM, Huber AR. A differentiated approach to assess the diagnostic usefulness of a rapid particle gell immunoassay for the detection of antibodies against heparin-platelet factor 4 in cardiac surgery patients. Blood Coag Fibrinolysis 2003; 14: 99-106.
12. Visentin GP, Malik M, Cyganiak KA, Aster RH. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes. J Lab Clin Med 1996; 128: 376-83.
13. Lillo-Le Louet A, Boutouyrie P, Alhenc-Gelas M, Le Beller C, Gautier I, Aiach M, Lasne D. Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass. J Thromb Haemost 2004; 2: 1882-8.
14. Nader ND, Khadra WZ, Reich NT, Bacon DR, Salerno TA, Panos AL. Blood product use in cardiac revascularization: comparison of on- and off-pump techniques. Ann Thorac Surg 1999, 2004; 68: 1640-3.
15. Gerdisch M, Wallis DE, Birger-Botkin S, Prechel M, Jeske WP, Jacobs K, Castellanof Y, Messmole HL, Bakhos M, Walenga JM. Pre-operative platelet count as baseline is not predictive of heparin-induced thrombocytopenia following cardiac surgery. The HITME (Heparin-Induced Thrombocytopenia Multicenter Evaluation) Trial. Blood 2002; 100 688a.
16. Lasne D, Lillo-Le LA, Louet A, Boutouyrie P, Kreft-Jais C, Aiach M. Early diagnosis of heparin-induced thrombocytopenia (HIT) after cardiopulmonary bypass (CPB) through the platelet count profile. Thromb Haemost 2001; (Suppl.): P1933.
17. Pouplard C, May MA, Regina S, Maakaroun A, Fusciardi J, Gruel Y. Changes in the platelet count after cardiopulmonary bypass can efficiently predict the development of pathogenic heparin-dependent antibodies. Blood 2002; 100: 16a.
18. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1998; 101: 502-7.
19. Warkentin TE, Sheppard JI, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 2000; 96: 1703-8.
20. Pouplard C, Amiral J, Borg JY, Laporte-Simitsidis S, Delahousse B, Gruel Y. Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 1999; 1115: 700-6.